This article is more than 5 years old. Information may no longer be current.

STAAR reports net loss for 2014

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical reported a GAAP net loss of $8.4 million, or $0.22 on a per diluted share basis, in 2014 compared with a net income of $398,000, or $0.01 on a per diluted share basis, in 2013, according to a press release.

Full-year sales totaled $75 million, a 4% increase compared with 2013 and a 6% increase on a constant currency basis.

Sales in the fourth quarter of 2014 were $16.6 million, a decrease from $18.9 million reported in the same quarter in 2013.

Sales of the Visian ICL were reported at $9 million in the fourth quarter of 2014 compared with $11.5 million in the same quarter in 2013. The decrease was attributed to approximately $2 million in orders that the company was unable to fill by the end of the year and timing of orders received from the distributor in Korea, the release said.

IOL sales were reported at $5.5 million in the fourth quarter of 2014 compared with $6.6 million in the same quarter of 2013.